The Scientist

» biotechnology and immunology

Most Recent

image: Do Microbes Trigger Alzheimer’s Disease?

Do Microbes Trigger Alzheimer’s Disease?

By | September 1, 2017

The once fringe idea is gaining traction among the scientific community.

6 Comments

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

0 Comments

image: Organs on Chips

Organs on Chips

By | August 28, 2017

Scientists hope that these devices will one day replace animal models of disease and help advance personalized medicine.

3 Comments

image: Custom-Made Molecules

Custom-Made Molecules

By | August 21, 2017

A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.

0 Comments

image: Dengue Infection Impairs Immune Defense Against Zika

Dengue Infection Impairs Immune Defense Against Zika

By | August 18, 2017

A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.

0 Comments

image: The Ever-Expanding T-Cell World: A Primer

The Ever-Expanding T-Cell World: A Primer

By | August 7, 2017

Researchers continue to identify new T-cell subtypes—and devise ways to use them to fight cancer. The Scientist attempts to catalog them all.

2 Comments

Another case of HIV remission emerges, this time in a South African girl diagnosed as an infant and disease-free for more than eight years.

0 Comments

image: Mammalian Immunity: What’s RNAi Got to Do with It?

Mammalian Immunity: What’s RNAi Got to Do with It?

By | July 21, 2017

A new study adds to the evidence that mammalian cells can use small interfering RNAs to defend against viruses, but questions remain about physiological importance.

1 Comment

Using single-cell RNA sequencing, scientists characterize new populations of dendritic cells and monocytes.

0 Comments

image: T Cells That Drive Toxic Shock in Mice Identified

T Cells That Drive Toxic Shock in Mice Identified

By | June 20, 2017

Overzealous activity by mucosa-associated invariant T (MAIT) cells in response to bacterial toxins can lead to illness instead of stopping it.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech